Answers are grounded in this paper and cite their sources.
Maladaptive trained immunity (MTI) establishes pathogenic innate immune memory that amplifies the immune response to recurrent chronic inflammatory diseases such as periodontitis, but erasing this memory remains challenging. In this study, we identified neutrophil extracellular traps (NETs) as key mediators of periodontitis-induced MTI that reprogrammed bone marrow epigenetics and transcriptomics to amplify inflammation upon secondary challenge. Thus, we designed a NET-inhibiting bioengineered platform (tPA@AGNs-DNase I) to erase MTI and prevent recurrent inflammation. This platform was constructed by encapsulating tPA within activated gelated neutrophils (AGNs) and conjugating DNase I onto the surface by glycoengineering and click chemistry. Leveraging the inflammation-homing property of AGNs, the platform enabled co-delivery of two enzymes: DNase I degraded the DNA scaffold of NETs, while tPA disrupted fibrin‒neutrophil engagement to block NETosis, thereby achieving synergistic NET clearance. Local periodontal administration of tPA@AGNs-DNase I not only resolved primary inflammation but also reversed established MTI by restoring aberrant bone marrow epigenetic and transcriptional reprogramming, thereby markedly attenuating recurrent hyperinflammation and alveolar bone loss in a religature-induced periodontitis model. Collectively, this work provides a bioengineered platform that erases central MTI via in situ NET clearance, offering a paradigm-shifting strategy to control chronic inflammatory disease recurrence.
No takes yet. Share an insight, caveat, or question.
方 莉 et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: